Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
CNY 2.91
(-9.63%)
CNY 2.91
(-9.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -63.45 Million CNY | -292.4% |
| 2022 | -16.17 Million CNY | 86.85% |
| 2021 | -122.97 Million CNY | -109.8% |
| 2020 | -58.61 Million CNY | 51.38% |
| 2019 | -120.55 Million CNY | -169.08% |
| 2018 | 174.52 Million CNY | 6.78% |
| 2017 | 163.44 Million CNY | 60.68% |
| 2016 | 101.72 Million CNY | 61.55% |
| 2015 | 62.96 Million CNY | 38.04% |
| 2014 | 45.61 Million CNY | 684.49% |
| 2013 | 5.81 Million CNY | 120.3% |
| 2012 | -28.63 Million CNY | -163.53% |
| 2011 | 45.07 Million CNY | -6.06% |
| 2010 | 47.98 Million CNY | -15.93% |
| 2009 | 57.08 Million CNY | 23.72% |
| 2008 | 46.13 Million CNY | -8.27% |
| 2007 | 50.3 Million CNY | 83.97% |
| 2006 | 27.34 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -9.82 Million CNY | -1689.58% |
| 2024 Q1 | 2.99 Million CNY | 121.13% |
| 2024 Q2 | 618.26 Thousand CNY | -79.34% |
| 2023 Q4 | -14.16 Million CNY | 21.34% |
| 2023 Q2 | -29.17 Million CNY | -1283.8% |
| 2023 FY | -63.45 Million CNY | -292.4% |
| 2023 Q1 | -2.1 Million CNY | 93.52% |
| 2023 Q3 | -18 Million CNY | 38.3% |
| 2022 Q1 | -11.2 Million CNY | 89.65% |
| 2022 Q3 | -13.04 Million CNY | -169.32% |
| 2022 Q2 | -4.84 Million CNY | 56.77% |
| 2022 FY | -16.17 Million CNY | 86.85% |
| 2022 Q4 | -32.53 Million CNY | -149.42% |
| 2021 Q1 | -23.94 Million CNY | -115.18% |
| 2021 Q4 | -108.28 Million CNY | -100.68% |
| 2021 FY | -122.97 Million CNY | -109.8% |
| 2021 Q3 | -53.95 Million CNY | -309.92% |
| 2021 Q2 | -13.16 Million CNY | 45.02% |
| 2020 Q2 | -29.47 Million CNY | -18.83% |
| 2020 FY | -58.61 Million CNY | 51.38% |
| 2020 Q4 | 157.76 Million CNY | 401.15% |
| 2020 Q1 | -24.8 Million CNY | 98.72% |
| 2020 Q3 | -52.38 Million CNY | -77.71% |
| 2019 FY | -120.55 Million CNY | -169.08% |
| 2019 Q4 | -1.93 Billion CNY | -5307.05% |
| 2019 Q1 | 71.37 Million CNY | 347.56% |
| 2019 Q3 | -35.84 Million CNY | -104.13% |
| 2019 Q2 | -17.56 Million CNY | -124.6% |
| 2018 FY | 174.52 Million CNY | 6.78% |
| 2018 Q3 | 43.95 Million CNY | -45.5% |
| 2018 Q4 | -28.83 Million CNY | -165.59% |
| 2018 Q2 | 80.65 Million CNY | 2.41% |
| 2018 Q1 | 78.75 Million CNY | 1095.8% |
| 2017 Q4 | -7.9 Million CNY | -113.69% |
| 2017 Q3 | 57.77 Million CNY | 0.35% |
| 2017 Q2 | 57.57 Million CNY | 2.81% |
| 2017 Q1 | 56 Million CNY | 497.8% |
| 2017 FY | 163.44 Million CNY | 60.68% |
| 2016 Q1 | 29.3 Million CNY | 138.0% |
| 2016 Q4 | 9.36 Million CNY | -55.1% |
| 2016 Q3 | 20.86 Million CNY | -50.55% |
| 2016 FY | 101.72 Million CNY | 61.55% |
| 2016 Q2 | 42.18 Million CNY | 43.95% |
| 2015 Q3 | 13.77 Million CNY | -29.87% |
| 2015 Q2 | 19.64 Million CNY | 13.91% |
| 2015 Q1 | 17.24 Million CNY | 14.3% |
| 2015 Q4 | 12.31 Million CNY | -10.6% |
| 2015 FY | 62.96 Million CNY | 38.04% |
| 2014 Q3 | 6.58 Million CNY | -30.52% |
| 2014 Q2 | 9.48 Million CNY | -34.4% |
| 2014 Q1 | 14.45 Million CNY | 4.68% |
| 2014 FY | 45.61 Million CNY | 684.49% |
| 2014 Q4 | 15.08 Million CNY | 128.92% |
| 2013 Q1 | -6.12 Million CNY | 53.81% |
| 2013 FY | 5.81 Million CNY | 120.3% |
| 2013 Q3 | 3.28 Million CNY | 163.73% |
| 2013 Q4 | 13.81 Million CNY | 319.91% |
| 2013 Q2 | -5.16 Million CNY | 15.74% |
| 2012 Q3 | -6.79 Million CNY | 51.03% |
| 2012 Q1 | 5.28 Million CNY | -17.47% |
| 2012 Q2 | -13.86 Million CNY | -362.6% |
| 2012 Q4 | -13.25 Million CNY | -95.24% |
| 2012 FY | -28.63 Million CNY | -163.53% |
| 2011 FY | 45.07 Million CNY | -6.06% |
| 2011 Q1 | 19.53 Million CNY | 83.39% |
| 2011 Q2 | 8.96 Million CNY | -54.08% |
| 2011 Q3 | 10.17 Million CNY | 13.41% |
| 2011 Q4 | 6.39 Million CNY | -37.1% |
| 2010 Q2 | 7.15 Million CNY | -57.99% |
| 2010 Q3 | 13.14 Million CNY | 83.64% |
| 2010 Q4 | 10.65 Million CNY | -18.94% |
| 2010 FY | 47.98 Million CNY | -15.93% |
| 2010 Q1 | 17.03 Million CNY | 15.9% |
| 2009 Q3 | 13.32 Million CNY | 1.19% |
| 2009 Q1 | 15.89 Million CNY | 0.0% |
| 2009 FY | 57.08 Million CNY | 23.72% |
| 2009 Q4 | 14.69 Million CNY | 10.36% |
| 2009 Q2 | 13.16 Million CNY | -17.21% |
| 2008 FY | 46.13 Million CNY | -8.27% |
| 2007 FY | 50.3 Million CNY | 83.97% |
| 2006 FY | 27.34 Million CNY | 0.0% |